Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Launched
3y ago
2023-05-30 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    May 30, 2023 · 3y agoWebsite

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
selfh.st★ 203 Stars · 4 ForksGPL-3.0HTML
2024-09-23Source

eBook management and reading platform

Open Source & Self-Hosting

GitHub · MCP / Skill
Last commit 2026-11-05
GitHub Stars
★ 203
Forks
4
License
GPL-3.0
Primary language
HTML

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2023-05-30

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Public pricing: Open Source (GPL-3.0)Raw source text; structured plans are extracted after website capture.

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
Home
bookheaven.ggarrido.dev/ Snapshot 2026-11-09

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does BookHeaven get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is BookHeaven and what platforms does it support?
BookHeaven is catalogued under Books & Reading: BookHeaven Server. Supported platforms: Mobile App, API.
Is BookHeaven open source?
BookHeaven has a public repository (https://github.com/BookHeaven/BookHeaven.Server) under the GPL-3.0 license, recording 203 GitHub stars, and supporting self-hosted deployment.Source

Related products in this category

Entertainment & Media / Books & Reading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.